Biomedical Safety Technologies introduces New Medical Products at CDC National Immunization Conference

(Biomedical Safety Technologies is newest ISIPS Member)

March 15, 2003  -  Biomedical Safety Technologies, LLC, in association with MicroStim® Technologies, Inc., announced the introduction of three novel medical devices at the 2003 CDC National Immunization Conference.  The three medical devices are specific dressings that provide greater safety for the medical community and patient alike.  Drs. Joel S. Rossen and Robert L. Watson have created a new category of medical devices which they call “Pre-Procedure Bandages™”.  These new devices afford a greatly enhanced degree of protection because they are applied before the skin is punctured.  By the time the skin is broken, the isolation of the site has already occurred with the Injection Patch™ and is completed within a fraction of a second with the Invasive Site Patch.  Human exposure to bloodborne pathogens is minimized and contaminated sharps can be disposed of immediately.    

The three innovative medical products include the Injection Patch, the Invasive Site Patch, and the After Patch. These unique dressings are designed to protect the patient, the attending clinician, and family members from exposure to bloodborne pathogens and needlestick injuries.  Dr. Damon Miller, Medical Director of Biomedical Safety Technologies recently said, “The people administering the vaccine also have to be protected. The protection of healthcare workers from needlestick injuries and prevention of cross contamination of the intimate contacts of the person vaccinated should be a primary concern.”  Dr. Miller cites the case of the San Francisco Department of Public Health that is not allowing health workers to be vaccinated for smallpox due to concerns that the vaccinated health care workers might be injured or infect the patients they work with by transferring the vaccine virus to them.  Since the city can’t afford to let newly vaccinated workers take two weeks off while their vaccination site heals, they are choosing not to allow vaccinations at all.

“Attention to the safety issues in the smallpox vaccine program is essential,” said Dr. Miller. ”If the healthcare community and the public perceive the vaccinations as unsafe the program will never succeed.  We have the products that can make this a safer program including the Injection Patch, Invasive Site Patch, and After Patch.”

INJECTION PATCH™

The Injection Patch covers an injection site prior to the puncture.  The injection is performed through the clear central elastomer film that seals immediately when the needle is removed.   The Injection Patch allows the needle that is contaminated by exposure to the patient’s blood to be disposed of immediately, rather than after a lengthy bandaging procedure.  The Injection patch eliminates the need for post-injection bandaging because the site is dressed prior to the injection.  Any bleeding or discharge that occurs is contained behind the plastic window. 

INVASIVE SITE PATCH™

The sterile Invasive Site Patches™  are designed to cover a proposed injection or procedure site prior to the procedure. They enhance provider and patient safety from needlestick injury and exposure to bloodborne pathogens, because completion of bandaging the site occurs within a moment after the procedure is completed. A variety of procedures can be performed through the open window including vaccinations, injections, or even minor surgeries.  The healthcare provider can immediately focus full attention on disposal of the contaminated sharp. The procedure is performed through an open door and then the door is closed and sealed to secure and isolate the site. (left)

The door has a view window that allows the injection site to be observed post-procedure. This permits adverse reactions to be observed at the earliest possible moment rather than only at the time that the bandage is being changed.  When the tab is pulled down, the flap pulls over the site and seals the door. (right)

The absorbent materials surrounding the site wick away fluids and exudates without putting any pressure on the site. The site is left to heal, untouched by any bandaging materials. The entire site is sealed by a breathable layer of polyurethane and a polyethylene window.  The clear medical grade polyethylene window protects the site. The site may be observed without having to change the bandage and without risking exposure to contaminated body fluids.

THE AFTER-PATCH™

The After-Patch is a bandage that is designed to cover a vaccination or procedure site after the Invasive Site Patch has been removed. It protects the site from trauma or impact and prevents infectious exudates from entering or escaping from the lesion. A hard polyethylene plastic domed cap in the center of the patch protects the site from mechanical assault. It shields the site by creating a ‘safe zone’ where nothing touches the skin, thus protecting the site during the healing process.

These new patches are available by contacting Biomedical Safety Technologies, LLC. at 954-720-4383.

Contact:

     Biomedical Safety Technologies, LLC

     Dr. Joel Rossen, CEO

     954 720-4383

     info@microstim.com

or

     ISIPS

     Ron Stoker, Executive Director

     801-280-8797

     ron@isips.org